Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-06-30, Stock:JNJ, The news for the past five days is as follows:
2020-06-23: NEWS1: How the NACP ETF helps investors align their assets with their values.NEWS2: J&J Fails To Overturn Baby Powder Verdict, Damages Cut To $2.12B.NEWS3: Johnson & Johnson Baby-Powder Ruling Affirmed, Penalty Cut.NEWS4: J&J loses bid to overturn baby powder verdict, but damages cut to $2.12 billion.NEWS5: Damages verdict against Johnson & Johnson lowered to $2.1 bln in Missouri talc case.
2020-06-24: NEWS1: Johnson & Johnson Option Trader Makes $1.7M Bet On 17% Upside.NEWS2: Appeals Court Rules Against J&J but Cuts Talc- Powder Verdict.NEWS3: Johnson & Johnson Damages Halved To $2.12B By Court In Missouri But Verdict Stands.NEWS4: PRESS DIGEST- New York Times business news - June 24.NEWS5: PRESS DIGEST - Wall Street Journal - June 24.
2020-06-25: NEWS1: Bayer Isn’t Out of the Roundup Woods as 30,000 Claims Remain.NEWS2: Moderna Is the Latest Coronavirus Vaccine Partner for Catalent.NEWS3: Vaccine makers face biggest medical manufacturing challenge in history.NEWS4: INSIGHT-Vaccine makers face biggest medical manufacturing challenge in history.NEWS5: Unilever, rivals mull changes amid global backlash against skin-lightening products.
2020-06-26: NEWS1: J&J scraps late-stage study testing Stelara for lupus.NEWS2: Regeneron Used a Charity to Pay Kickbacks, Justice Department Alleges.NEWS3: J&J scraps late-stage study testing Stelara for lupus.
2020-06-29: NEWS1: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.NEWS2: Race for a COVID-19 vaccine has drug makers scaling up manufacturing — before one is developed.NEWS3: J&J (JNJ) Discontinues Phase III Study of Stelara for Lupus.

Answer: Rise